The comparative study of efficacy and safety in the treatment with mixed-type insulin to combined therapy with long-acting insulin analog and GLP-1 recepter agonist in type 2 DM. - The comparative study from mixed-type insulin to long-acting insulin analog and GLP-1 recepter agonist.

Hyogo College Of Medicine Division of Diabetes,Endocrinology and Metabolism,Department of Internal Medicine0 sites10 target enrollmentFebruary 25, 2015

ConditionsType 2 Diabetes Mellitus

Overview

Phase: 未知
Intervention: Not specified
Conditions: Type 2 Diabetes Mellitus
Sponsor: Hyogo College Of Medicine Division of Diabetes,Endocrinology and Metabolism,Department of Internal Medicine
Enrollment: 10
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

February 25, 2015

End Date

February 25, 2017

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

Hyogo College Of Medicine Division of Diabetes,Endocrinology and Metabolism,Department of Internal Medicine

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•Type 1 diabetes mellitus Subjects who have been experienced severe ketosis, diabetic coma or precoma within 6 months Subjects in pregnant women, lactating women, the potential or planned are pregnant Subjects with severe infection, before and just after surgery or severe injury Subjects treated with adrenocorticosteroid Subjects with severe hepatic dysfunction Subjects with impaired insulin secretion Subjects with a history of pancreatitis or with a pancreatitis Subjects with a history of a malignant tumor or with a malignant tumor Subjects who have been determined to be unsuitable for the attending physician